{"doc_id": "PMID-8562886.txt", "sent_id": "", "tokens": ["The", "effect", "of", "Toremifene", "on", "the", "expression", "of", "some", "genes", "in", "human", "mononuclear", "cells", "."], "sentence": "The effect of Toremifene on the expression of some genes in human mononuclear cells .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8562886.txt", "sent_id": "", "tokens": ["Toremifene", "exerts", "multiple", "and", "varied", "effects", "on", "the", "gene", "expression", "of", "human", "peripheral", "mononuclear", "cells", "."], "sentence": "Toremifene exerts multiple and varied effects on the gene expression of human peripheral mononuclear cells .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8562886.txt", "sent_id": "S3", "tokens": ["After", "short-term", ",", "in", "vitro", "exposure", "to", "therapeutical", "levels", ",", "distinct", "changes", "in", "P-glycoprotein", ",", "steroid", "receptors", ",", "p53", "and", "Bcl-2", "expression", "take", "place", "."], "sentence": "After short-term , in vitro exposure to therapeutical levels , distinct changes in P-glycoprotein , steroid receptors , p53 and Bcl-2 expression take place .", "event_mentions": [{"id": "E1", "event_type": "Regulation", "trigger": {"text": "changes", "start": 11, "end": 11}, "arguments": [{"entity_id": "T4", "text": "expression", "role": "Theme"}]}, {"id": "E2", "event_type": "Regulation", "trigger": {"text": "changes", "start": 11, "end": 11}, "arguments": [{"entity_id": "T4", "text": "expression", "role": "Theme"}]}, {"id": "E3", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 21, "end": 21}, "arguments": [{"entity_id": "T2", "text": "Bcl-2", "role": "Theme"}]}, {"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 21, "end": 21}, "arguments": [{"entity_id": "T1", "text": "p53", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "p53", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T2", "text": "Bcl-2", "entity_type": "Protein", "start": 20, "end": 20}, {"id": "T3", "text": "changes", "entity_type": "Regulation", "start": 11, "end": 11}, {"id": "T4", "text": "expression", "entity_type": "Gene_expression", "start": 21, "end": 21}]}
{"doc_id": "PMID-8562886.txt", "sent_id": "", "tokens": ["In", "view", "of", "the", "increasing", "use", "of", "antiestrogens", "in", "cancer", "therapy", "and", "prevention", ",", "there", "is", "obvious", "merit", "in", "long-term", "in", "vivo", "studies", "to", "be", "conducted", "."], "sentence": "In view of the increasing use of antiestrogens in cancer therapy and prevention , there is obvious merit in long-term in vivo studies to be conducted .", "event_mentions": [], "entity_mentions": []}
